◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › 0-9 › 3759

Pharmaron Beijing Co., Ltd. (3759) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-10-02

Pharmaron Beijing Co., Ltd. (3759) operates in the Biotechnology industry and is headquartered in Beijing, China with about 27,316 employees. Its market capitalization is roughly HK$57 billion. In the fiscal year ended 2025-12-31, 3759 reported CNY 14.1B in revenue and CNY 1.7B in net income.

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.

Interactive charts & full statements → Open the 3759 valuation workbench →

3759 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 14.1BCNY 12.3BCNY 11.5BCNY 10.3B—
Gross ProfitCNY 4.9BCNY 4.2BCNY 4.1BCNY 3.8B—
Operating Income (EBIT)CNY 2.2BCNY 1.9BCNY 1.8BCNY 1.8B—
Net IncomeCNY 1.7BCNY 1.8BCNY 1.6BCNY 1.4B—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3759 Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-31
Total RevenueCNY 4.0BCNY 3.6BCNY 4.0B—CNY 3.3BCNY 3.1B
Gross ProfitCNY 1.3BCNY 1.2BCNY 1.5B—CNY 1.1BCNY 1.0B
Operating Income (EBIT)CNY 563MCNY 496MCNY 713M—CNY 526MCNY 446M
Net IncomeCNY 415MCNY 335MCNY 523M—CNY 396MCNY 306M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3759 Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid(CNY 531M)(CNY 542M)(CNY 445M)(CNY 405M)—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3759 Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-06-302025-03-31
Dividends Paid(CNY 56M)(CNY 47M)(CNY 46M)(CNY 46M)(CNY 41M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3759 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 27.1BCNY 23.9BCNY 26.5BCNY 20.5B—
Total LiabilitiesCNY 11.4BCNY 9.7BCNY 13.2BCNY 9.7B—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3759 viewer.

Other Companies in Biotechnology

← 3758All “0-9” companies3760 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.